Linzess 72 MCG capsule UU 30S
Ended Awarded Last action
- Contract number
- SPE2DR26F46DL
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $1,334
Award facts
- Contract value 100% obligated
- $1,334.42 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for LINZESS 72 MCG capsules (30-count units) with a ceiling value of $1,334.42. This firm fixed-price delivery order, issued on December 3, 2025, with an ultimate completion date of December 4, 2025, represents a non-set-aside competitive award. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under the company's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a comprehensive $999.99 billion global pharmaceutical support vehicle running through December 2026 that enables the company to supply a wide range of pharmaceutical products and medical supplies to military healthcare programs worldwide.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, serves as a critical vendor for federal medical procurement through the Defense Logistics Agency's Medical Supply Chain. The company has established itself through multiple competitive awards delivering brand-name and generic medications, vaccines, and specialized medical supplies across diverse therapeutic domains to support military and veteran healthcare systems. LINZESS (linaclotide) is a prescription medication used to treat irritable bowel syndrome and chronic constipation, and this delivery order fulfills immediate supply requirements for the Defense Health Agency and other federal healthcare customers through the prime IDC vehicle.
Quick answers
Who was awarded contract SPE2DR26F46DL?
SPE2DR26F46DL was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on December 3, 2025.
How much is contract SPE2DR26F46DL worth?
The government has obligated $1,334 on SPE2DR26F46DL.
Is contract SPE2DR26F46DL an order under another contract?
Yes. SPE2DR26F46DL is a delivery order under SPE2DR25D2101, an indefinite delivery contract.
Was contract SPE2DR26F46DL competed?
The extent of competition for SPE2DR26F46DL was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award